4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Precigen, Inc. (PGEN) operates in the Biotechnology industry and is headquartered in Germantown, United States with about 160 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, PGEN reported $10M in revenue and ($251M) in net income.
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
Interactive charts & full statements → Open the PGEN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $10M | $4M | $6M | $27M | — |
| Gross Profit | $5M | ($0M) | $0M | $21M | — |
| Operating Income (EBIT) | ($107M) | ($95M) | ($89M) | ($75M) | — |
| Net Income | ($251M) | ($126M) | ($96M) | $28M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $23M | $5M | $3M | $1M | $1M | — |
| Gross Profit | $21M | $3M | $2M | ($0M) | $0M | — |
| Operating Income (EBIT) | ($6M) | ($22M) | ($34M) | ($28M) | ($23M) | — |
| Net Income | ($8M) | ($24M) | ($146M) | ($27M) | ($54M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $156M | $145M | $151M | $216M | — |
| Total Liabilities | $135M | $107M | $32M | $90M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PGEN viewer.
About TickerBase · Data methodology & sources